nicotine has been researched along with rosiglitazone in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 15 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Spangler, JG | 1 |
| Bruin, JE; Gerstein, HC; Holloway, AC; Petrik, JJ | 1 |
| Alfaidy, N; Cesta, CE; Gerstein, HC; Holloway, AC; Kellenberger, LD; Petrik, JJ | 1 |
| Bruin, JE; Gerstein, HC; Holloway, AC; Hyslop, JR; Petrik, JJ; Raha, S; Tarnopolsky, MA | 1 |
| Cerny, LM; Rehan, VK; Sakurai, R; Torday, JS | 1 |
| Kenyon, NJ; Liu, J; O'Roark, EM; Rehan, VK; Sakurai, R; Torday, JS | 1 |
| Akbari, O; Kwong, K; Liu, J; Lombardi, V; Naeem, E; Rehan, VK; Tian, J; Torday, JS | 1 |
| Beebe, DA; Huang, C; Knight, DR; Schroeder, RL; Smith, AH; Sokolowski, SA; Wang, M | 1 |
| Liu, J; Rehan, VK; Sakurai, R | 1 |
| Cannon, DT; Liu, J; Rehan, VK; Rossiter, HB; Sakurai, R | 1 |
| Liu, J; Rehan, VK; Sakurai, R; Torday, JS; Wang, Y | 1 |
| Cucullo, L; Sivandzade, F | 1 |
20 other study(ies) available for nicotine and rosiglitazone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Bone biology and physiology: implications for novel osteoblastic osteosarcoma treatments?
Topics: Bone Neoplasms; Bone Remodeling; Caffeine; Calcium; Cell Line, Tumor; Cyclic AMP; Cytokines; Humans; Models, Biological; Nicotine; Osteoblasts; Osteosarcoma; Receptors, Adrenergic; Receptors, Glutamate; Rosiglitazone; Thiazolidinediones | 2008 |
Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth.
Topics: Animals; Animals, Newborn; Apoptosis; Cell Count; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Nicotine; Nicotinic Agonists; Pregnancy; Random Allocation; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2008 |
Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine.
Topics: Animals; Animals, Newborn; Blood Vessels; Cells, Cultured; Drug Evaluation, Preclinical; Female; Fertility; Hypoglycemic Agents; Infertility, Female; Maternal Exposure; Nicotine; Ovary; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2009 |
Rosiglitazone improves pancreatic mitochondrial function in an animal model of dysglycemia: role of the insulin-like growth factor axis.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetes, Gestational; Disease Models, Animal; Female; Glucose Intolerance; Hypoglycemic Agents; Insulin-Like Growth Factor I; Insulin-Secreting Cells; Mitochondria; Nicotine; Pregnancy; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2010 |
Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Base Sequence; beta Catenin; Cell Line; Cell Transdifferentiation; DNA Primers; Fibroblasts; Humans; Naphthalenes; Nicotine; PPAR gamma; Protein Kinase C; Pulmonary Alveoli; Receptors, Nicotinic; Rosiglitazone; Signal Transduction; Thiazolidinediones; Up-Regulation; Wnt Proteins | 2011 |
PPARγ agonist rosiglitazone prevents perinatal nicotine exposure-induced asthma in rat offspring.
Topics: Animals; Animals, Newborn; Asthma; Female; Methacholine Chloride; Nicotine; PPAR gamma; Pregnancy; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Rosiglitazone; Thiazolidinediones; Trachea | 2011 |
Sex-specific perinatal nicotine-induced asthma in rat offspring.
Topics: Airway Resistance; Animals; Animals, Newborn; Asthma; Disease Models, Animal; Female; Lung Compliance; Male; Muscle, Smooth; Nicotine; PPAR gamma; Pregnancy; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sex Characteristics; Smoking; Thiazolidinediones; Trachea | 2013 |
Effects of age on noninvasive assessments of vascular function in nonhuman primates: implications for translational drug discovery.
Topics: Age Factors; Animals; Brachial Artery; Drug Discovery; Endothelial Cells; Endothelium, Vascular; Female; Femoral Artery; Glucose Tolerance Test; Lipopolysaccharides; Macaca fascicularis; Male; Nicotine; Rosiglitazone; Stem Cells; Thiazolidinediones; Translational Research, Biomedical | 2013 |
PPAR-γ agonist rosiglitazone reverses perinatal nicotine exposure-induced asthma in rat offspring.
Topics: Animals; Asthma; Cells, Cultured; Female; Lung; Muscle Contraction; Nicotine; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Receptors, Nicotinic; Rosiglitazone; Thiazolidinediones | 2015 |
Impaired Lung Mitochondrial Respiration Following Perinatal Nicotine Exposure in Rats.
Topics: Animals; Animals, Newborn; Cell Respiration; Female; Gestational Age; Lung; Maternal Exposure; Mitochondria; Nicotine; Nicotinic Agonists; Oxidative Phosphorylation; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2016 |
Prevention of perinatal nicotine-induced bone marrow mesenchymal stem cell myofibroblast differentiation by augmenting the lipofibroblast phenotype.
Topics: Adipogenesis; Animals; Animals, Newborn; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Female; Gestational Age; Lipogenesis; Maternal Exposure; Mesenchymal Stem Cells; Muscle Development; Myofibroblasts; Nicotine; Nicotinic Agonists; Osteogenesis; Phenotype; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Rosiglitazone | 2018 |
Anti-Diabetic Countermeasures Against Tobacco Smoke-Dependent Cerebrovascular Toxicity: Use and Effect of Rosiglitazone.
Topics: Animals; Blood-Brain Barrier; Brain; Cerebrovascular Disorders; Cotinine; Diabetes Mellitus; Humans; Hypoglycemic Agents; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Nicotine; PPAR gamma; Rosiglitazone; Signal Transduction; Tobacco Smoking | 2019 |